Covid-19: Bangavax to get conditional approval for clinical trials, says BMRC

The National Research Ethics Committee of Bangladesh Medical Research Council (BMRC) today decided to approve Globe Biotech's Covid-19 vaccine, Bangavax, for human trials.

Globe Biotech will get the final nod on conducting clinical trials on humans only after meeting some conditions set by the BMRC, its director Prof Dr Ruhul Amin said this after a virtual meeting.

On January 17, Globe Biotech, the only Bangladeshi company trying to develop a Covid-19 vaccine, submitted a protocol to the BMRC for ethical approval to conduct Bangavax's clinical trials.